Drugs / UWD-19
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT06662227 | Oct 2024 → Dec 2027 | B-cell neoplasm, lymphoid leukemia | Wondercel Biotech (ShenZhen) | Suspended | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | UWD-19 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06662227 ↗ |